Cancer Cachexia Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 – ResearchAndMarkets.com

Cancer Cachexia Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 – ResearchAndMarkets.com




Cancer Cachexia Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Cancer Cachexia Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” report has been added to ResearchAndMarkets.com’s offering.

The global cancer cachexia market size reached US$ 2.0 Billion in 2022. Looking forward, the publisher expects the market to reach US$ 2.6 Billion by 2028, exhibiting a CAGR of 4.47% during 2022-2028.

Cancer Cachexia Market Trends:

The increasing prevalence of cancer and cachexia, especially amongst the rising geriatric populations, is facilitating the demand for advanced therapeutic treatment and drugs, which in turn, is primarily driving the market growth. This is further supported by the increasing awareness amongst consumers regarding the availability of novel therapeutic drugs to treat cancer cachexia. Additionally, the shifting inclination of patients toward combinational therapies for improving lean body mass (LBM) through pharmacological, non-pharmacological therapies and clinical trials is acting as another growth-inducing factor.

In line with this, the extensive utilization of several appetite stimulants, such as megestrol acetate, dexamethasone, and methylprednisolone, for improving digestion is also contributing to the market growth.

Moreover, significant technological advancements that are emphasizing on the development of effective medicines for cancer cachexia treatment are further propelling the market growth.

Apart from this, the numerous favorable initiatives being undertaken by the government bodies of various countries and non-governmental organizations (NGOs) for sensitizing people regarding the causes of cancer cachexia, their symptoms and benefits of using advanced treatments are creating a positive outlook for the market.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global cancer cachexia market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on therapeutics, mode of action and distribution channel.

Breakup by Therapeutics:

  • Progestogens
  • Corticosteroids
  • Combination Therapy
  • Others

Breakup by Mode of Action:

  • Appetite Stimulators
  • Weight Loss Stabilizers

Breakup by Distribution Channel:

  • Hospital Stores
  • Retail Pharmacy
  • Online Pharmacy

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Cancer Cachexia Market

6 Market Breakup by Therapeutics

7 Market Breakup by Mode of Action

8 Market Breakup by Distribution Channel

9 Market Breakup by Region

10 SWOT Analysis

11 Value Chain Analysis

12 Porters Five Forces Analysis

13 Price Analysis

14 Competitive Landscape

Companies Mentioned

  • AAVogen Inc.
  • Actimed Therapeutics Ltd.
  • Aphios Corporation
  • Artelo Biosciences Inc.
  • AVEO Pharmaceuticals Inc.
  • Fresenius Kabi AG (Fresenius SE & Co. KGaA)
  • Helsinn Healthcare SA
  • Merck & Co. Inc.
  • NGM Biopharmaceuticals Inc.
  • Pfizer Inc.
  • Tetra Bio-Pharma

For more information about this report visit https://www.researchandmarkets.com/r/tvuk4y

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900